Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Cyclically Adjusted FCF per Share: ¥0.33 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688336 Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
75 GF Score
Price ¥42.95
GF Value ¥67.71
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted FCF per Share?

Sunshine Guojian Pharmaceutical (Shanghai) Co SHSE:688336 +3.20% 75 Cyclically Adjusted FCF per Share is ¥0.33 as of Mar. 2026. GuruFocus rates SHSE:688336 with a GF Score™ of 75/100 and a GF Value™ of ¥67.71 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Sunshine Guojian Pharmaceutical (Shanghai) Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥-0.228. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.33 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sunshine Guojian Pharmaceutical (Shanghai) Co's average Cyclically Adjusted FCF Growth Rate was 450.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-05), Sunshine Guojian Pharmaceutical (Shanghai) Co's current stock price is ¥42.95. Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.33. Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF of today is 130.15.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sunshine Guojian Pharmaceutical (Shanghai) Co was 849.66. The lowest was 103.33. And the median was 216.51.


Sunshine Guojian Pharmaceutical (Shanghai) Co  (SHSE:688336) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=42.95/0.33
=130.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sunshine Guojian Pharmaceutical (Shanghai) Co was 849.66. The lowest was 103.33. And the median was 216.51.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted FCF per Share Related Terms


Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted FCF per Share Chart

Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.07 0.06 0.36

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.05 0.35 0.36 0.33

SHSE:688336 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:688336
75GF Score
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sunshine Guojian Pharmaceutical (Shanghai) Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.228/116.3033*116.3033
=-0.228

Current CPI (Mar. 2026) = 116.3033.

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201112 0.043 92.885 0.054
201203 0.062 94.367 0.076
201206 0.037 93.495 0.046
201209 0.070 94.482 0.086
201212 0.085 95.237 0.104
201303 -0.006 96.372 -0.007
201306 -0.037 95.984 -0.045
201309 0.056 97.332 0.067
201612 0.000 102.600 0.000
201712 0.000 104.500 0.000
201812 0.000 106.500 0.000
201903 0.024 107.700 0.026
201906 0.115 107.700 0.124
201909 0.256 109.800 0.271
201912 0.170 111.200 0.178
202003 -0.065 112.300 -0.067
202006 -0.065 110.400 -0.068
202009 -0.056 111.700 -0.058
202012 -0.120 111.500 -0.125
202103 -0.151 112.662 -0.156
202106 -0.230 111.769 -0.239
202109 -0.042 112.215 -0.044
202112 -0.169 113.108 -0.174
202203 0.044 114.335 0.045
202206 0.005 114.558 0.005
202209 -0.009 115.339 -0.009
202212 -0.028 115.116 -0.028
202303 -0.072 115.116 -0.073
202306 0.052 114.558 0.053
202309 0.102 115.339 0.103
202312 0.135 114.781 0.137
202403 0.051 115.227 0.051
202406 -0.024 114.781 -0.024
202409 -0.021 115.785 -0.021
202412 -0.004 114.893 -0.004
202503 0.068 115.116 0.069
202506 0.040 114.907 0.040
202509 2.751 115.471 2.771
202512 0.148 115.832 0.149
202603 -0.228 116.303 -0.228

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.33 mean?
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) has a Cyclically Adjusted FCF per Share of ¥0.33 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted FCF per Share too high?
Sunshine Guojian Pharmaceutical (Shanghai) Co's current Cyclically Adjusted FCF per Share is ¥0.33. Overall, Sunshine Guojian Pharmaceutical (Shanghai) Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted FCF per Share of ¥0.33 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. Sunshine Guojian Pharmaceutical (Shanghai) Co's current Cyclically Adjusted FCF per Share is ¥0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) is currently considered Possible Value Trap. The stock's GF Value™ is ¥67.71, compared to a current price of ¥42.95 — trading 36.6% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.33. Sunshine Guojian Pharmaceutical (Shanghai) Co's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336), the current Cyclically Adjusted FCF per Share is ¥0.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Overvalued in 2026?

Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co stock appears to be undervalued. The current stock price of ¥42.95 is trading 36.6% below its estimated GF Value™ of ¥67.71. GuruFocus considers Sunshine Guojian Pharmaceutical (Shanghai) Co to be Possible Value Trap.

Key valuation signals for SHSE:688336:

  • Cyclically Adjusted FCF per Share: ¥0.33
  • GF Value™: ¥67.71 vs. price of ¥42.95 (36.6% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description

Address No.399 Libing Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
75GF Score

Get the complete analysis for SHSE:688336

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥42.95
Price
¥67.71
GF Value